VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV was delisted on the 7th of August, 2024.
102 hedge funds and large institutions have $306M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 40 increasing their positions, 15 reducing their positions, and 7 closing their positions.
457% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 7
310% more capital invested
Capital invested by funds: $74.5M → $306M (+$231M)
167% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 15
44% more funds holding
Funds holding: 71 → 102 (+31)
22% more call options, than puts
Call options by funds: $2.65M | Put options by funds: $2.17M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$16.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.27M |
| 3 |
Two Sigma Investments
New York
|
+$2.61M |
| 4 |
BlackRock
New York
|
+$2.57M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
-$2.81M |
| 2 |
PAM
Premier Asset Management
Chicago,
Illinois
|
-$693K |
| 3 |
PMFA
Plante Moran Financial Advisors
Southfield,
Michigan
|
-$287K |
| 4 |
GAI
General American Investors
New York
|
-$275K |
| 5 |
Renaissance Technologies
New York
|
-$235K |
VBIV Hedge Fund Activity: Q2 2020 in Review
102 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q2 2020, worth a combined $306M — up 310% from $74.5M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new VBIV positions and 7 closed out — a net gain of 32 holders — while 40 added to existing stakes and 15 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $16.7M. The largest seller was First Midwest Bank Trust Division, cutting an estimated $2.81M.
- 102 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q2 2020, up from 71 in Q1 2020.
- Funds reported $306M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q2 2020, up 310% quarter-over-quarter.
- 39 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q2 2020 and 7 closed out, a net change of +32 holders.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q2 2020 was Perceptive Advisors, an estimated $16.7M added.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q2 2020 was First Midwest Bank Trust Division, an estimated $2.81M sold.
Based on aggregated 13F filings for Q2 2020.